Anti-CD19 CAR-T Cells

SKU:BHC18200254
Overview
Click light‑blue chips for details
Anti-CD19 CAR-T Cells is a Cell Pool (Human origin, BSL-1) from BPS Bioscience. Designed for positive control for anti-cd19 car-t cells screening inhibitors or activators of anti-cd19 car-t cytotoxicity design and optimize co-culture cytotoxicity assay workflows.
Species Human
Biosafety Level BSL-1
Product Type Cell Pool
Mycoplasma Tested Confirmed Negative
Storage Liquid Nitrogen
Options selector
Catalog no. Size
78171-1 1 Vial
78171-2 5 Vials
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size (2) — 1 Vial, 5 Vials
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage.
  • Shipping: cold-chain shipment (typically with ice packs).
  • Upon receipt: store at the recommended temperature as soon as possible.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Mfr No 78171
Product Type
  • Cell Pool
Shipping -80°C (dry ice)
Species Human
Storage Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage.

Scientific Background

CD19 (also known as Cluster of Differentiation 19, B-lymphocyte surface antigen B4, or CVID3) is a glycoprotein expressed at the surface of B lymphocytes through most phases of B cell maturation. It is strictly required for B cell terminal differentiation. Mutations in the CD19 gene cause severe immune-deficiency syndromes associated with impaired antibody production such as CVID3 (common variable immuno-deficiency 3). The majority of B cell malignancies express normal to high levels of CD19, which is a nearly ideal target for cancer immunotherapy. Blinatumomab, a CD19/CD3 bi-specific T cell engager (BiTE) has been approved for relapsed/refractory B-precursor ALL (Acute lymphoblastic leukemia). In addition, CD19 was the target of the first approved CAR-T cell therapy.

Product Description

CAR-T

The anti-CD19 CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector, BPS Bioscience, #78601). These ready-to use CAR-T cells express an anti-CD19 CAR consisting the ScFv of CD19 (clone FMC63) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains. These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

Product Specifications

Transfection Method Lentivirus
Supplied As Each vial contains 2 x 106 cells in 1 ml of CryoStor® CS10)
Harmonized Tariff Code 3002-5900

Quality Control & Validation

✓ Mycoplasma-Tested

The cells have been screened to confirm the absence of Mycoplasma species.

Safety & Handling

⚠ Avoid freeze/thaw cycles. Donors have been screened and determined negative for: - Hepatitis B (anti-HBc EIA, HBsAg EIA) - Hepatitis C (anti-HCV EIA) - Human Immunodeficiency Virus (HIV-1/HIV-2 plus O) - Human T-Lymphotropic Virus (HTLV-I/II) - HIV-1/HCV/HBV - West Nile Virus - Trypanasoma cruzi Note: Testing cannot guarantee that any sample is completely virus-free. These cells should be treated as potentially infectious and appropriate biological safety level 2 precautions should be used.

Regulatory Information

License RequiredNo
Living Modified OrganismYes

License Disclosure

Troubleshooting Guide: For all further questions, please email support@bpsbioscience.com.

Related Products

Related Products: Cat. #90184-A, 60690, 79714, 78170

What biosafety level is required for this cell line?

This product is classified as BSL-1. Standard microbiological practices (gloves, lab coat, eye protection) are sufficient. No specialized containment facility is required beyond a clean bench. Consult your institutional IBC for GMO registration requirements.

Has this cell line been tested for mycoplasma contamination?

Yes. The cells have been screened to confirm the absence of Mycoplasma species. We recommend that you independently confirm mycoplasma-negative status after receipt and periodically during routine culture using a validated detection kit.

What are the recommended storage conditions?

Store this product at Liquid Nitrogen. Specifically: Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage. Transfer cells from dry-ice shipping to the recommended storage immediately upon receipt. Avoid repeated freeze-thaw cycles, which reduce viability and may alter expression characteristics.

Is a license required to use this product?

A standard research-use license applies (No). Commercial applications or transfer to other facilities may require a separate license. Contact BPS Bioscience for details.

What method was used to generate this cell line?

This stable cell line was generated using Lentivirus for transgene delivery into the parental host. The stably integrated cells were selected using the appropriate resistance marker and verified for expression prior to cryopreservation.

Can't find the cell line you need—or require a custom engineered model for your study? We offer end-to-end support for diverse research needs, including:

  • Cell line sourcing and selection (species, tissue, and disease model matching)
  • Stable cell line engineering (overexpression, knockdown, knockout via CRISPR/Cas9, shRNA, sgRNA)
  • Reporter gene integration (GFP, RFP, luciferase, fluorescent/bioluminescent constructs)
  • Genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles)
  • Inducible expression systems (Tet-On/Off and regulatable constructs)
  • Drug resistance marker selection (puromycin, G418, hygromycin, and others)
  • Custom growth and media optimisation for specific assay requirements
  • Scale-up production for high-throughput screening campaigns
  • Authentication and QC services (STR profiling, mycoplasma testing, viability assessment)

Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

Matches this product
15%OFF
15% Off Cancer Antibodies
Ends Sep 30 ONCO15
Matches this product
10% OFF
10% OFF CELL LINES-Limited-Time Offer
Ends Sep 30 CELL10
$50 OFF
$50 Off All ELISA Kits
Limited time ELISA50
FREE SAMPLE
Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme
Limited time offer – availa... FREESAMPLE
FREE SAMPLE
Free Sample – MycoFold™ Growth Factors
Limited time offer – availa... Request Free Sample

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today